Synergizing Light and Machine Learning to Comprehensively Reveal Coronary Plaque Composition
- PMID: 35024501
- PMCID: PMC8733742
- DOI: 10.1016/j.jacbts.2021.10.016
Synergizing Light and Machine Learning to Comprehensively Reveal Coronary Plaque Composition
Keywords: artificial intelligence; coronary artery disease; fluorescence lifetime; optical coherence tomography.
Conflict of interest statement
This work has been supported by NIH/NHLBI K08-HL130465 (EAO), and NIH/NHLBI R01-HL150538 and R01-HL137593 (FAJ). Dr Osborn is a consultant with Abbott Vascular, and Canon, Philips; and a member of the scientific advisory board for Dyad Medical, and holds equity in Dyad Medical. Dr Jaffer has received funds for sponsored research from Canon, Siemens, Shockwave, Teleflex, and Mercator; is a consultant with Boston Scientific, Siemens, Magenta Medical, IMDS, Asahi Intecc, Biotronik, Philips, and Intravascular Imaging; and has equity interest in Intravascular Imaging Inc, DurVena; and with Massachusetts General Hospital has licensing arrangements with Terumo, Canon, and Spectrawave, for which they have a right to receive royalties. Dr Housitis has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
- doi: 10.1016/j.jacbts.2021.10.005
References
-
- BrainyQuotes Francis of Assisi quotes. https://www.brainyquote.com/quotes/francis_of_assisi_753007 Accessed October 29, 2021.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
